Library / regulatory-reference
Moldova: Ministry of Health and the Medicines and Medical Devices Agency (AMDM)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
Moldova's medicines regulation rests with the Ministry of Health and the Medicines and Medical Devices Agency, known by its Romanian initials AMDM, which handles registration and oversight.
Moldova imports most of its medicines, mainly from European suppliers, and the agency's registration decisions are shaped by the country's European-association orientation.
How products enter the market
Medicines require marketing authorization after evaluation of quality, safety and efficacy documentation, and establishments across the supply chain are licensed and inspected.
Post-market work includes safety monitoring and recalls, with progressive alignment of procedures toward European norms.
Regional and international role
Moldova's European orientation drives its regulatory alignment work, adopting technical requirements modeled on European frameworks.
Its experience shows how association agreements translate into day-to-day regulatory change in a small market.
Using this profile
The ministry and agency publish regulations and announcements in Romanian through official portals, which are the primary sources for current rules; the ministry portal is listed in this profile's internal reference record.
For cross-country comparison: Moldova illustrates the alignment-driven regulator: a small import market rebuilding its rules toward European norms.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.